NPWTR: Negative Pressure Wound Therapy Registry

Sponsor
U.S. Wound Registry (Other)
Overall Status
Unknown status
CT.gov ID
NCT02467998
Collaborator
(none)
50,000
1

Study Details

Study Description

Brief Summary

The goal of the Negative Pressure Wound Therapy Registry (NPWTR) for Wounds is to provide real world patient data from electronic health records submitted to meet Stage 2 Meaningful Use in order to understand the effectiveness and safety of various NPWT devices and methods among patients with chronic wounds and ulcers. Randomized, controlled trials to establish product efficacy routinely exclude patients with the co-morbid conditions common to patients seen in usual clinical practice and thus the results of these Randomized Controlled Trials (RCTs) tend to be non-generalizable. Little is known about the effectiveness of NPWT among typical patients. Patient registries are also ideal for assessing long term safety issues in these devices.

Detailed Description

The purpose of the Negative Pressure Wound Therapy Registry (NPWTR)) for Wounds and Ulcers is to provide comparative effectiveness data on NPWT including different NPWT devices, and safety data on NPWT (e.g. the frequency of adverse events experienced by typical NPWT patients).

NPWT promotes wound healing by applying a vacuum through a special sealed dressing. The mechanical micro-deformation of the wound bed in response to suction has been shown to stimulate and accelerate the formation of new blood vessels (angiogenesis). The continuous vacuum removes fluid and reduces edema, thereby increasing tissue oxygen levels. The vacuum may be applied continuously or intermittently, depending on the type of wound being treated and the clinical objectives. Depending on the NPWT device, a variety of dressings are placed into the wound bed in conjunction with NPWT, and a variety of suction pressures may be applied.

The diversity of NPWT devices and the rate at which they are becoming available for clinical use make it impossible to perform randomized controlled trials to compare their effectiveness against one another. Effectiveness in real world patients is the best current option to understand the role of NPWT in wound healing.

Hospital based outpatient wound centers participating in the US Wound Registry agree to provide data as part of quality initiatives including participation in PQRS, and to meet their Stage 2 Meaningful use criteria. The NPWTR is a subset of the USWR (Chronic Disease Registry) data. All patient data from all participating outpatient clinics are transmitted to the USWR where data are available for benchmarking, PQRS and other initiatives. Data used for comparative effectiveness research is HIPAA de-identified.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
50000 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
The Registry of Negative Pressure Wound Therapy for Chronic Wounds and Ulcers
Actual Study Start Date :
Jan 1, 2005
Anticipated Primary Completion Date :
Jan 1, 2020

Arms and Interventions

Arm Intervention/Treatment
NPWT treated wounds

NPWT from any FDA cleared NPWT device including

Device: NPWT
SVAP polyurethane foam, RENASYS foam, RENASYS gauze, AMD gauze, VAC white sponge, VAC black sponge, applied with various NPWT devices, in addition to various dressings to protect wound edges
Other Names:
  • the VAC
  • Renasys
  • Pico
  • Engenix
  • Sved
  • SNaP
  • extriCARE
  • Prospera
  • Invia Liberty
  • Invia Motion
  • Avance
  • Halo MINI
  • COBALTT
  • Halo XT
  • Outcome Measures

    Primary Outcome Measures

    1. Healing [In days from the start of NPWT until the date healing or closure by other means, or of death from any cause, whichever came first, assessed up to 12 months]

      Time-to-event for wound closure

    Secondary Outcome Measures

    1. Duration of NPWT [In days from date of NPWT initiation until the date of last NPWT treatment regardless of patient outcome, assessed up to 12 months]

      Counting total amount of therapy delivered

    2. Side effects and adverse Events During Therapy [Events occurring between initial treatment and cessation of NPWT treatment. Event outcome information will be as recorded or status at 30 days following onset]

      Overall catalog of event types and occurrences. Score in % for: bleeding, retention of foam or other interface in wound bed, periwound breakdown, worsening of wound such as exposure of deep structure, and wound infection

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Provision of NPWT
    Exclusion Criteria:
    • patients not undergoing NPWT

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 St. Luke's Wound Care Clinic The Woodlands Texas United States 77384

    Sponsors and Collaborators

    • U.S. Wound Registry

    Investigators

    • Principal Investigator: Caroline Fife, MD, US Wound Registry

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    U.S. Wound Registry
    ClinicalTrials.gov Identifier:
    NCT02467998
    Other Study ID Numbers:
    • CDR003
    First Posted:
    Jun 10, 2015
    Last Update Posted:
    May 1, 2018
    Last Verified:
    Apr 1, 2018

    Study Results

    No Results Posted as of May 1, 2018